| Title | Neuropharmacology |
| Abbreviation | Neuropharmacology |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Pharmacology (Q1); Cellular and Molecular Neuroscience (Q2) |
| h-index | 184 |
| Overall Rank/Ranking | 2697 |
| SCImago Journal Rank (SJR) | 1.307 |
| Impact Score | 4.84 |
| Publisher | Elsevier Ltd. |
| Country | United Kingdom |
| ISSN | 00283908, 18737064 |
| Best Quartile | Q1 |
| Coverage History | 1962-2022 |
Neuropharmacology is a journal covering the technologies/fields/categories related to Pharmacology (Q1); Cellular and Molecular Neuroscience (Q2). It is published by Elsevier Ltd.. The overall rank of Neuropharmacology is 2697. According to SCImago Journal Rank (SJR), this journal is ranked 1.307. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 184. The best quartile for this journal is Q1.
The ISSN of Neuropharmacology journal is 00283908, 18737064. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Neuropharmacology is cited by a total of 5494 articles during the last 3 years (Preceding 2022).
The Impact IF 2022 of Neuropharmacology is 4.84, which is computed in 2023 as per its definition. Neuropharmacology IF is decreased by a factor of 0.14 and approximate percentage change is -2.81% when compared to preceding year 2021, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2022 of Neuropharmacology is 4.84. If the same downward trend persists, Impact IF may fall in 2023 as well.
| Year | Impact IF |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 4.84 |
| 2021 | 4.98 |
| 2020 | 4.70 |
| 2019 | 4.54 |
| 2018 | 4.40 |
| 2017 | 4.37 |
| 2016 | 5.24 |
| 2015 | 5.43 |
| 2014 | 5.65 |
Neuropharmacology has an h-index of 184. It means 184 articles of this journal have more than 184 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Neuropharmacology is 00283908, 18737064. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Neuropharmacology is 2697. According to SCImago Journal Rank (SJR), this journal is ranked 1.307. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 1.307 |
| 2021 | 1.323 |
| 2020 | 1.760 |
| 2019 | 1.638 |
| 2018 | 1.780 |
| 2017 | 2.043 |
| 2016 | 2.355 |
| 2015 | 2.547 |
| 2014 | 2.410 |
| Year | Ranking |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 2697 |
| 2021 | 2605 |
| 2020 | 1697 |
| 2019 | 1899 |
| 2018 | 1671 |
| 2017 | 1340 |
| 2016 | 1040 |
| 2015 | 906 |
| 2014 | 991 |
Neuropharmacology is published by Elsevier Ltd.. It's publishing house is located in United Kingdom. Coverage history of this journal is as following: 1962-2022. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Neuropharmacology is Neuropharmacology. This abbreviation ('Neuropharmacology') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Pharmacology (Q1); Cellular and Molecular Neuroscience (Q2), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Neuropharmacology latest impact IF is 4.84. It's evaluated in the year 2022. The highest and the lowest impact IF or impact score of this journal are 5.65 (2014) and 4.37 (2017), respectively, in the last 9 years. Moreover, its average IS is 4.91 in the previous 9 years.
The Neuropharmacology has an SJR (SCImago Journal Rank) of 1.307, according to the latest data. It is computed in the year 2023. In the past 9 years, this journal has recorded a range of SJR, with the highest being 2.547 in 2015 and the lowest being 1.307 in 2022. Furthermore, the average SJR of the Neuropharmacology over the previous 9-year period stands at 4.91.
The latest h-index of the Neuropharmacology is 184.
The Neuropharmacology is published by the Elsevier Ltd., with its country of publication being the United Kingdom.
The Neuropharmacology is currently ranked 2697 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 9 years, this journal has experienced varying rankings, reaching its highest position of 906 in 2015 and its lowest position of 2697 in 2022.
The standard ISO4 abbreviation for the Neuropharmacology is Neuropharmacology.
Neuropharmacology is classified as a journal that the Elsevier Ltd. publishes.
The Neuropharmacology encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Neuropharmacology is assigned the following International Standard Serial Numbers (ISSN): 00283908, 18737064.
The best quartile for the Neuropharmacology is Q1 (2022).
The Neuropharmacology coverage history can be summarized as follows: 1962-2022.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Journal of Business Economics and Management | journal | 10343 | Vilnius Gediminas Technical University | 45 | 2.81 |
| Proceedings of the Spring Technical Conference of the ASME Internal Combustion Engine Division | conference and proceedings | 17477 | 16 | 0.00 | |
| Entrepreneurship Theory and Practice | journal | 338 | Wiley-Blackwell | 185 | 12.75 |
| International Journal of Mathematical Education in Science and Technology | journal | 10040 | Taylor and Francis Ltd. | 39 | 1.33 |
| International Journal of Parallel, Emergent and Distributed Systems | journal | 15843 | Taylor and Francis Ltd. | 23 | 1.28 |
| Marine Biology Research | journal | 13573 | Taylor and Francis Ltd. | 42 | 1.06 |
| Tekstilec | trade journal | 19217 | Faculty of Natural Sciences and Engineering, Tekstilec | 14 | 0.73 |
| Population Review | journal | 17841 | Sociological Demography Press | 13 | 0.73 |
| Rinsan Shikenj Oha/Journal of the Hokkaido Forest Products Research Institute | journal | 25369 | Hoikkaido Forest Products Research Institute | 4 | 0.00 |
| Archives of the Balkan Medical Union | journal | 23243 | Balkan medical union | 10 | 0.24 |
| Year | Impact Score (IS) |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 4.84 |
| 2021 | 4.98 |
| 2020 | 4.70 |
| 2019 | 4.54 |
| 2018 | 4.40 |
| 2017 | 4.37 |
| 2016 | 5.24 |
| 2015 | 5.43 |
| 2014 | 5.65 |
